DERMABOND™ PRINEO™ Skin Closure System
DERMABOND PRINEO Skin Closure System provides a flexible microbial barrier with 99% protection in vitro for 72 hours against organisms commonly responsible for SSIs.1,*
DERMABOND PRINEO Skin Closure System was shown to provide statistically significant greater skin holding strength than skin staples or subcuticular 4-0 MONOCRYL (poliglecaprone 25) suture.2,**
* Staphylococcus epidermidis, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecium.
** In an ex-vivo study, more load in N was required to create a 3 ±1 mm gap between skin edges approximated with DERMABOND PRINEO System, than with subcuticular 4-0 MONOCRYL Suture or PROXIMATE ETHICON ENDO SURGERY skin staples (p=0.00).
1. Ethicon Inc, 054564-160609, EMEA DERMABOND PRINEO Claims, April 2017, Data on File.
2. Ethicon Inc, 054550-160609, EMEA DERMABOND PRINEO Claims, April 2017, Data on File.